ArticleBone marrow transplantation2024

A phase 1 dose-escalation study of low-dose lenalidomide maintenance post-allogeneic stem cell transplantation for high-risk acute myeloid leukaemia or myelodysplastic syndrome.

Ray Mun Koo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.